Engineered Extracellular Vesicles for Targeted Drug Delivery to Muscle
Technology
Extracellular vesicles (EVs) are lipid nanoparticles containing functional molecular cargo, such as proteins, RNA, and DNA, that are released by cells in order to influence the functioning of other cells. Since they are naturally occurring lipid nanoparticles produced by nearly every cell-type in the body, EVs can deliver therapeutic compounds and result in reduced toxicity compared to other drug delivery technologies. Although much progress has been made in engineering EVs with targeting properties for various cancers, connective and cardiac tissues, a great need exists for a targeted-drug delivery system for the treatment of neuromuscular pathologies, such as cancer cachexia, muscular dystrophies, and other muscle-wasting conditions. Modified viral vectors, such as adeno-associated viruses (AAV), are typically used as the delivery vehicles for gene therapies/editing technologies. The inventors at UD have generated EV formulations derived from human embryonic kidney cells that have been modified in culture to express specific proteins with muscle-targeting properties in the EV membrane, thus enhancing the delivery of the EV cargo to muscle cells/tissue. This technology enables the generation of EVs displaying muscle-targeting proteins at the outer EV membrane, increasing the specificity for delivery of therapeutic compounds to muscle and potentially diminishing the toxicity of treatments.
Benefits
- EVs are less immunogenic than AAVs that are typically used in delivering therapeutic compounds.
- Increases the specificity for delivery of therapeutic compounds to muscle cells/tissue.
- Avoids adverse events associated with off-target effects of therapeutic compounds administered intravenously, diminishing the toxicity of treatments.
Applications
- Can be used by pharmaceutical and drug manufacturing companies for a targeted-drug delivery system for the treatment of neuromuscular pathologies, such as cancer cachexia, muscular dystrophies, and other muscle-wasting conditions.